Kelly Shi
Stock Analyst at Jefferies
(2.66)
# 2,164
Out of 4,981 analysts
32
Total ratings
50%
Success rate
5.11%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $129 → $148 | $145.93 | +1.42% | 2 | Aug 13, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $23 → $28 | $12.66 | +121.17% | 1 | Jul 7, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $31 → $44 | $18.94 | +132.31% | 1 | Apr 25, 2025 | |
| VSTM Verastem | Initiates: Buy | $15 | $9.72 | +54.32% | 1 | Apr 10, 2025 | |
| OPT Opthea | Downgrades: Underperform | $1 | $3.41 | -70.67% | 1 | Mar 25, 2025 | |
| TIL Instil Bio | Upgrades: Buy | $11 → $52 | $23.96 | +117.03% | 2 | Jan 7, 2025 | |
| FHTX Foghorn Therapeutics | Maintains: Buy | $18 → $14 | $5.19 | +169.75% | 2 | Dec 16, 2024 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $13 → $19 | $21.81 | -12.88% | 2 | Sep 11, 2024 | |
| ASND Ascendis Pharma | Maintains: Buy | $174 → $196 | $195.58 | +0.21% | 2 | Aug 13, 2024 | |
| ARTV Artiva Biotherapeutics | Initiates: Buy | $21 | $2.56 | +720.31% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $15.55 | +137.94% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $6 | $2.48 | +141.94% | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $46 | $61.11 | -24.73% | 3 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $83.10 | -2.53% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $19.69 | +77.76% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $1.84 | +1,856.52% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $52.62 | -69.59% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $47.00 | -14.89% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.81 | +315.80% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $2.60 | +207.69% | 1 | Aug 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $0.81 | +3,232.51% | 1 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $17.93 | +190.02% | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $1.56 | +1,630.77% | 1 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $2.25 | +1,366.67% | 1 | Mar 8, 2021 |
Insmed
Aug 13, 2025
Maintains: Buy
Price Target: $129 → $148
Current: $145.93
Upside: +1.42%
Cogent Biosciences
Jul 7, 2025
Maintains: Buy
Price Target: $23 → $28
Current: $12.66
Upside: +121.17%
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31 → $44
Current: $18.94
Upside: +132.31%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $9.72
Upside: +54.32%
Opthea
Mar 25, 2025
Downgrades: Underperform
Price Target: $1
Current: $3.41
Upside: -70.67%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11 → $52
Current: $23.96
Upside: +117.03%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $5.19
Upside: +169.75%
Centessa Pharmaceuticals
Sep 11, 2024
Maintains: Buy
Price Target: $13 → $19
Current: $21.81
Upside: -12.88%
Ascendis Pharma
Aug 13, 2024
Maintains: Buy
Price Target: $174 → $196
Current: $195.58
Upside: +0.21%
Artiva Biotherapeutics
Aug 13, 2024
Initiates: Buy
Price Target: $21
Current: $2.56
Upside: +720.31%
Jun 28, 2024
Initiates: Buy
Price Target: $37
Current: $15.55
Upside: +137.94%
Jun 10, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $2.48
Upside: +141.94%
May 20, 2024
Maintains: Buy
Price Target: $35 → $46
Current: $61.11
Upside: -24.73%
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $83.10
Upside: -2.53%
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $19.69
Upside: +77.76%
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $1.84
Upside: +1,856.52%
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $52.62
Upside: -69.59%
Aug 15, 2022
Initiates: Buy
Price Target: $40
Current: $47.00
Upside: -14.89%
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $4.81
Upside: +315.80%
Aug 3, 2022
Initiates: Buy
Price Target: $8
Current: $2.60
Upside: +207.69%
Mar 4, 2022
Initiates: Buy
Price Target: $27
Current: $0.81
Upside: +3,232.51%
Aug 3, 2021
Initiates: Buy
Price Target: $52
Current: $17.93
Upside: +190.02%
Apr 13, 2021
Initiates: Buy
Price Target: $27
Current: $1.56
Upside: +1,630.77%
Mar 8, 2021
Initiates: Buy
Price Target: $33
Current: $2.25
Upside: +1,366.67%